Related Experiment Video
Updated: Jun 1, 2026
10:07
Investigation of Macrophage Polarization Using Bone Marrow Derived Macrophages
Published on: June 23, 2013
Krüppel-like factor 4 regulates macrophage polarization.
Xudong Liao1, Nikunj Sharma, Fehmida Kapadia
1Case Cardiovascular Research Institute, Department of Medicine, Harrington-McLaughlin Heart and Vascular Institute,University Hospitals Case Medical Center, Case Western Reserve University, Cleveland, Ohio, USA.
The Journal of Clinical Investigation
|June 15, 2011
Summary
Krüppel-like factor 4 (KLF4) regulates macrophage polarization, promoting anti-inflammatory M2 macrophages and inhibiting pro-inflammatory M1 types. KLF4 deficiency impairs host defense and metabolic health.
Area of Science:
- Immunology
- Molecular Biology
- Metabolism
Background:
- Macrophage polarization into M1 (pro-inflammatory) and M2 (anti-inflammatory) subsets is crucial for host defense and inflammation.
- The molecular mechanisms governing macrophage polarization remain incompletely understood.
Purpose of the Study:
- To identify novel regulators of macrophage polarization.
- To elucidate the role of Krüppel-like factor 4 (KLF4) in macrophage differentiation and function.
Main Methods:
- Analysis of KLF4 expression in M1 and M2 macrophages in vitro.
- In vivo studies using human inflammatory models.
- Mechanistic studies involving Stat6 and NF-κB pathways.
- Generation of myeloid-specific KLF4-deficient mice.
Main Results:
- KLF4 expression is significantly upregulated in M2 macrophages and downregulated in M1 macrophages.
- KLF4 cooperates with Stat6 to promote M2 gene expression and suppress M1 targets.
- KLF4 deficiency leads to increased pro-inflammatory responses, enhanced bactericidal activity, and metabolic alterations in macrophages.
- KLF4-deficient mice exhibit delayed wound healing and metabolic dysfunction, including obesity and insulin resistance.
Conclusions:
- KLF4 is a critical regulator of macrophage polarization.
- KLF4 plays a key role in balancing inflammatory responses and maintaining metabolic homeostasis.
- Targeting KLF4 may offer therapeutic potential for inflammatory and metabolic diseases.
